| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | 0.00062 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0005 | 1 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.00068 | 1 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00046 | 1 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.00057 | 1 |